Sign in

CIK 0001237831

  • Large accelerated filer

GLOBUS MEDICAL INC

Sign in to watch
Ticker
GMED
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043744954
Phone
+1 610-930-1800
Business address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,794,049
in 3 filings, $425K under 10b5-1 plans

Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$5.4M Director sold 100% of stake
  2. RHOADS ANN D −$425K Director sold 12% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 RHOADS ANN D Director Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −15,384 0
2021-01-14 RHOADS ANN D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2021-01-14 Lemaitre Dan Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2021-01-14 Davidar David D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2021-01-14 ZARRILLI STEPHEN T Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2021-01-14 TOBIN JAMES R Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2021-01-14 Douglas Robert Andrew Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2021-01-14 Huller Kelly SVP, GC, Corporate Secretary Grant or award · Stock Option (Right to Buy Class A Common Stock) +30,000 30,000
2021-01-14 Pfeil Keith W SVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy Class A Common Stock) +40,000 40,000
2021-01-14 Scavilla Daniel T EVP, Chief Commercial Officer Grant or award · Stock Option (Right to Buy Class A Common Stock) +50,000 50,000
2021-01-14 Demski David M President, CEO Grant or award · Stock Option (Right to Buy Class A Common Stock) +175,000 175,000
2021-01-14 Paul David C Executive Chairman Grant or award · Stock Option (Right to Buy Class A Common Stock) +100,000 100,000
2020-12-28 Huller Kelly SVP, GC, Corporate Secretary Exercise or conversion +2,000 $11.28 $23K 2,000
2020-12-28 Huller Kelly SVP, GC, Corporate Secretary Sale −2,000 $66.15 $132K 0
2020-12-28 Huller Kelly SVP, GC, Corporate Secretary Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −2,000 0
2020-12-17 Demski David M President, CEO Exercise or conversion +15,864 $24.10 $382K 164,719
2020-12-17 Demski David M President, CEO Sale −164,719 $64.20 $10.6M 0
2020-12-17 Demski David M President, CEO Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) −15,864 0
2020-12-16 Demski David M President, CEO Exercise or conversion +3,125 $43.77 $137K 151,980
2020-12-16 Demski David M President, CEO Exercise or conversion +3,125 $43.58 $136K 155,105

Page 16 of 25 · 498 trades